|
Scientific Advisors
Joy A. Cavagnaro, Ph.D., DABT, RAC
Dr. Cavagnaro is assisting ApoImmune in defining its regulatory strategy. She has significant industry experience having served as Vice President of Regulatory Affairs at Human Genome Sciences, Inc. She also played a significant role at the FDA Center for Biologics Evaluation and Research ("CBER") before rejoining industry, having helped shape the development of CBER to address issues from the emerging biotechnology industry.
Donald M. Miller, M.D., Ph.D.
Dr. Miller is a medical oncologist and is Director of the James Graham Brown Cancer Center at the University of Louisville and Associate Vice President of Health Affairs. Since Dr. Miller's arrival, the Brown Cancer Center has made considerable progress towards its goal of designation by the National Cancer Institute as a Comprehensive Cancer Center.
Scott J. Antonia, M.D., Ph.D.
Dr. Antonia is a medical oncologist and a member in residence with the H. Lee Moffit Cancer Center at the University of South Florida. He directs a translational research program that has the overall goal of developing novel immunotherapeutic strategies for the treatment of cancer patients.
back to Leadership
|
|
|
